{"id":21388,"date":"2016-01-30T19:48:49","date_gmt":"2016-01-31T03:48:49","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/01\/research-device-claims-to-suppress-brain-cancer-cell-growth"},"modified":"2017-04-24T22:41:37","modified_gmt":"2017-04-25T05:41:37","slug":"research-device-claims-to-suppress-brain-cancer-cell-growth","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/01\/research-device-claims-to-suppress-brain-cancer-cell-growth","title":{"rendered":"Research: Device Claims To Suppress Brain-Cancer Cell Growth"},"content":{"rendered":"<p><a class=\"blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/research-device-claims-to-suppress-brain-cancer-cell-growth.jpg\"><\/a><\/p>\n<p>One key question can it help control Glioblastoma.<\/p>\n<hr>\n<p>A new \u201cwearable\u201d device being tested to suppress brain-cancer cell growth in patients ended its clinical trials early with positive results. Optune is a battery powered device researchers claim will extend the life of a patient with \u201cnewly diagnosed glioblastoma\u201d when it is paired with traditional temozolomide chemotherapy. Researches were confident enough in its effectiveness to end the clinical trials (which ran from July 2009 to November 2014) of the device early. The device is likely not \u201cthe cure for cancer,\u201d but it is a step forward in extending the life expectancy of brain-cancer patients and more research will be needed to see if it may be effective on other forms of cancer.<\/p>\n<blockquote><p>\u201cWith this new data, it appears the tumor-treating fields should be used upfront and become a standard of care. We should add this modality to what we\u2019re currently doing for our patients,\u201d said Dr. Maciej Mrugala, a brain-cancer specialist who led UW Medicine\u2019s participation in the clinical trial.<\/p>\n<p>\u201cYou get almost five months\u2019 survival benefit. It may not sound like a lot, but if you\u2019re living with this diagnosis, this is a meaningful improvement,\u201d said Mrugala. UW Medicine was one of the first 15 U.S. providers to employ the novel tumor-treating therapy; now there are more than 200.<\/p>\n<p>Glioblastoma multiforme is the most common primary brain tumor and a highly aggressive cancer. The Optune device, manufactured by Novocure, disrupts cancer-cell reproduction by sending alternating positive and negative charges between small ceramic discs embedded in on four sides of the mesh cap.<\/p><\/blockquote>\n<p><a href=\"http:\/\/techaeris.com\/2016\/01\/30\/research-device-claims-to-suppress-brain-cancer-cell-growth\/\" target=\"_blank\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>One key question can it help control Glioblastoma. A new \u201cwearable\u201d device being tested to suppress brain-cancer cell growth in patients ended its clinical trials early with positive results. Optune is a battery powered device researchers claim will extend the life of a patient with \u201cnewly diagnosed glioblastoma\u201d when it is paired with traditional temozolomide [\u2026]<\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47,1977],"tags":[],"class_list":["post-21388","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience","category-wearables"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/21388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=21388"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/21388\/revisions"}],"predecessor-version":[{"id":51103,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/21388\/revisions\/51103"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=21388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=21388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=21388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}